← back to search

Hua Hao

Nanchang University · CN
Area of research
Immunology · Cancer Research
Research interest
Research interests include Cancer research, Medicine, Chemistry, Tumor microenvironment, Angiogenesis, and Receptor.
h-index
citations
322
works
19
NIH funding
primary concept
email

Recent publications

The environmental exposome in heart failure risk and progression
Nature Reviews Cardiology 2026cited by 1position: middledoi
Baicalin reduces sunitinib-induced cardiotoxicity in renal carcinoma PDX model by inhibiting myocardial injury, apoptosis and fibrosis
Frontiers in Pharmacology 2025cited by 3position: middledoi
Establishment of matched bladder cancer PDX and PDX-derived organoid model and evaluation of anti-tumor efficacy of abemaciclib
Clinical & Translational Oncology 2024cited by 4position: middledoi
Role of cancer-associated fibroblasts in colorectal cancer and their potential as therapeutic targets
Biochemical and Biophysical Research Communications 2023cited by 15position: lastdoi
Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer
Journal of Cancer Research and Clinical Oncology 2023cited by 7position: middledoi
Macrophage phenotype-switching in cancer
European Journal of Pharmacology 2022cited by 59position: lastdoi
Lipoxin A4 and its analog attenuate high fat diet-induced atherosclerosis via Keap1/Nrf2 pathway
Experimental Cell Research 2022cited by 13position: lastdoi
LipoxinA4 analog BML-111 protects podocytes cultured in high-glucose medium against oxidative injury via activating Nrf2 pathway
International Immunopharmacology 2022cited by 8position: firstdoi
BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway
International Immunopharmacology 2020cited by 14position: lastdoi
BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells
Immunology Letters 2020cited by 10position: lastdoi
The role of lipoxin in regulating tumor immune microenvironments
Prostaglandins & Other Lipid Mediators 2019cited by 13position: middledoi
Lipoxin A4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-κB signaling pathway
Prostaglandins & Other Lipid Mediators 2019cited by 10position: middledoi
Lipoxin A <sub>4</sub> attenuates LPS-induced acute lung injury via activation of the ACE2-Ang-(1-7)-Mas axis
Innate Immunity 2018cited by 39position: middledoi
Lipoxin A4 and its analog suppress hepatocarcinoma cell epithelial-mesenchymal transition, migration and metastasis via regulating integrin-linked kinase axis
Prostaglandins & Other Lipid Mediators 2018cited by 27position: lastdoi
BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system
Prostaglandins & Other Lipid Mediators 2018cited by 18position: middledoi
The response of the Oxford classification to steroid in IgA nephropathy: a systematic review and meta-analysis
Oncotarget 2017cited by 19position: middledoi
BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats
International Journal of Molecular Sciences 2016cited by 29position: middledoi
Lipoxin A4 Suppresses Lipopolysaccharide-Induced Hela Cell Proliferation and Migration via NF-κB Pathway
Inflammation 2014cited by 23position: firstdoi
Diabetes mellitus potentiates diffuse large B-cell lymphoma via high levels of CCL5
Molecular Medicine Reports 2014cited by 10position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaoyan Zhou · Fudan University9 papers (2014–2022)Fen Xu · Sun Yat-sen University6 papers (2014–2022)Yuanqiao He · Nanchang University6 papers (2014–2025)Yonghong Huang · Nanchang University3 papers (2016–2018)Fanrong Liu · Nanchang University3 papers (2014–2023)Liqing Wu · Nanchang University2 papers (2014–2014)Xiaodong Kuang · Nanchang University2 papers (2018–2018)Chao Hu · Nanchang University2 papers (2023–2024)Xiongbing Lu · Wake Forest University2 papers (2023–2024)Yun Yi · Nanchang University2 papers (2023–2025)Qiongfeng Chen · Nanchang University2 papers (2018–2018)Xuliang Luo · Nanchang University2 papers (2020–2020)Jing Xu · Anhui Medical University2 papers (2020–2020)Jiaqi Mei · Nanchang University2 papers (2023–2025)Ting Zhang · National Institutes of Health2 papers (2018–2019)Qingyu Wang · Capital Medical University2 papers (2020–2022)Lan Lin · Sun Yat-sen University Cancer Center2 papers (2020–2020)Jian Hao · Ministry of Education of the People's Republic of China2 papers (2014–2018)Liping Yan · Nanchang University2 papers (2020–2023)Hua Dai · Nanchang University2 papers (2014–2018)